XOMA Corp(XOMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XOMA XOMA Corp

Not Yet Opened 12-22 16:00:00 EST

25.58

+0.19

+0.75%

盘后25.58

+0.000.00%

16:04 EST

High26.06	Low25.39	Vol113.45K
Open25.42	D1 Closing25.39	Amplitude2.64%
Mkt Cap316.76M	Tradable Cap245.32M	Total Shares12.38M
T/O2.92M	T/O Rate1.18%	Tradable Shares9.59M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XOMA","market":"US","secType":"STK","nameCN":"XOMA Corp","latestPrice":25.58,"timestamp":1766437200000,"preClose":25.39,"halted":0,"volume":113450,"hourTrading":{"tag":"盘后","latestPrice":25.58,"preClose":25.58,"latestTime":"16:04 EST","volume":328,"amount":8390.24,"timestamp":1766437484856},"delay":0,"floatShares":9590400,"shares":12383103,"eps":0.821624,"marketStatus":"Not Yet Opened","change":0.19,"latestTime":"12-22 16:00:00 EST","open":25.42,"high":26.06,"low":25.39,"amount":2918201.0662,"amplitude":0.026388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.821624,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":517896000000,"exchange":"NASDAQ","adjPreClose":25.39,"postHourTrading":{"tag":"盘后","latestPrice":25.58,"preClose":25.58,"latestTime":"16:04 EST","volume":328,"amount":8390.24,"timestamp":1766437484856},"volumeRatio":1.129989,"impliedVol":0.223,"impliedVolPercentile":0.2129},"requestUrl":"/m/hq/s/XOMA","defaultTab":"news","newsList":[{"id":"2593482708","title":"XOMA Royalty Corporation announces $0.53906 Series A and $0.52344 Series B preferred stock dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2593482708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593482708?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:30","pubTimestamp":1766406615,"startTime":"0","endTime":"0","summary":"XOMA Royalty Corporation has announced quarterly cash dividends for its preferred stockholders. Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock will receive a dividend of $0.53906 per share, while holders of depositary shares representing the 8.375% Series B Cumulative Perpetual Preferred Stock will receive $0.52344 per depositary share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XOMA Royalty Corporation published the original content used to generate this news brief via GlobeNewswire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL4lNGxS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","BK4139","SG9999014021.USD","LU2095319765.USD","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4585","IE00B64PRP62.GBP","XOMA","BK4112"],"gpt_icon":0},{"id":"2591627960","title":"BRIEF-Xoma Royalty Enters Into Agreement To Acquire Generation Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2591627960","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591627960?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:34","pubTimestamp":1765838058,"startTime":"0","endTime":"0","summary":"BRIEF-Xoma Royalty Enters Into Agreement To Acquire Generation BioDec 15 (Reuters) - Generation Bio Co GBIO.O:XOMA ROYALTY ENTERS INTO AGREEMENT TO ACQUIRE GENERATION BIOGENERATION BIO CO - XOMA ROYAL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA9CD2M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4584","XOMA","GBIO"],"gpt_icon":0},{"id":"2591221176","title":"XOMA Royalty to Acquire Generation Bio for $4.29 Per Share Plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2591221176","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591221176?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:00","pubTimestamp":1765836016,"startTime":"0","endTime":"0","summary":"XOMA Royalty Corporation has entered into an agreement to acquire Generation Bio Co. for a cash price of $4.2913 per share at closing. In addition to the cash payment, Generation Bio stockholders will receive a non-transferable contingent value right  per share, entitling them to potential future milestone payments. The acquisition will add Generation Bio's cell-targeted lipid nanoparticles  delivery platform for small interfering RNA  and other nucleic acid therapies to XOMA Royalty's portfolio. The transaction is expected to close in February 2026, following the commencement of a tender offer and satisfaction of customary closing conditions. Approximately 15% of Generation Bio stockholders have already agreed to support the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL9Yx13R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","BK4588","GBIO","XOMA","LU0314104364.USD","SG9999014039.USD","BK4585","BK4584","BK4139","LU2210149790.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2591622938","title":"XOMA Royalty Enters Into Agreement to Acquire Generation Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622938","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591622938?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:00","pubTimestamp":1765836000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA9CD2M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4584","GBIO","XOMA"],"gpt_icon":0},{"id":"2591620601","title":"Investors Don't See Light At End Of XOMA Royalty Corporation's (NASDAQ:XOMA) Tunnel","url":"https://stock-news.laohu8.com/highlight/detail?id=2591620601","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591620601?lang=en_us&edition=fundamental","pubTime":"2025-12-16 03:01","pubTimestamp":1765825297,"startTime":"0","endTime":"0","summary":"You may think that with a price-to-sales (or \"P/S\") ratio of 6.6x XOMA Royalty Corporation ( NASDAQ:XOMA ) is a stock...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xoma/xoma-royalty/news/investors-dont-see-light-at-end-of-xoma-royalty-corporations","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xoma/xoma-royalty/news/investors-dont-see-light-at-end-of-xoma-royalty-corporations","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4139","NQmain","NVIW.SI","USJW.SI","BK4211","QID","XOMA","SQQQ","TQQQ","MNQmain","USAW.SI","QLD","PSQ",".IXIC","TSYW.SI"],"gpt_icon":1},{"id":"2590543792","title":"Why Is XOMA Royalty Stock Sinking Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590543792","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590543792?lang=en_us&edition=fundamental","pubTime":"2025-12-12 02:09","pubTimestamp":1765476540,"startTime":"0","endTime":"0","summary":"XOMA stock plunged after its partner Rezolute Inc. reported disappointing trial results for their product Ersodetug.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/11/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/11/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49343120/why-is-xoma-royalty-stock-sinking-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49343120/why-is-xoma-royalty-stock-sinking-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2360032135.SGD","BK4139","HI","LU2125154935.USD","RZLT","BK4161","LU0029874061.USD","LU2125154778.USD","LU0128526141.USD","XOMA"],"gpt_icon":0},{"id":"2590543689","title":"XOMA Royalty Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2590543689","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590543689?lang=en_us&edition=fundamental","pubTime":"2025-12-12 01:48","pubTimestamp":1765475280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XOMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 12:48 ET (17:48 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOMA"],"gpt_icon":0},{"id":"2590115405","title":"XOMA Royalty Corp (Pre-Reincorporation) : Leerink Partners Cuts Target Price to $45 From $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2590115405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590115405?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:06","pubTimestamp":1765462006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH11D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2590323756","title":"XOMA Royalty Initiated at Buy by LUCID CAPITAL MARKETS","url":"https://stock-news.laohu8.com/highlight/detail?id=2590323756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590323756?lang=en_us&edition=fundamental","pubTime":"2025-12-10 01:21","pubTimestamp":1765300860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XOMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 12:21 ET (17:21 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2589381343","title":"XOMA Royalty Completes Acquisition of Mural Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381343","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381343?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:39","pubTimestamp":1764945551,"startTime":"0","endTime":"0","summary":"XOMA Royalty  said Friday it has completed its previously announced acquisition of Mural Oncology .The acquisition was approved by Mural shareholders on Oct. 24 and later was sanctioned by the Irish High Court on Dec. 3, XOMA Royalty said.Mural Oncology shares will be delisted from Nasdaq and deregistered, XOMA Royalty said.Price: 31.13, Change: +0.13, Percent Change: +0.42","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XOMA","MURA","BK4139"],"gpt_icon":0},{"id":"2589381854","title":"BRIEF-Xoma Royalty Announces Closing Of Transaction To Acquire Mural Oncology PLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381854","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381854?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943235,"startTime":"0","endTime":"0","summary":"BRIEF-Xoma Royalty Announces Closing Of Transaction To Acquire Mural Oncology PLCDec 5 (Reuters) - Xoma Royalty Corp XOMA.O:XOMA ROYALTY ANNOUNCES CLOSING OF TRANSACTION TO ACQUIRE MURAL ONCOLOGY PLCSource text: ID:nGNX5VHzZVFurther company coverage: XOMA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUAYLFJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2589081884","title":"XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2589081884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589081884?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUAYLFJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2586250400","title":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250400?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:00","pubTimestamp":1764165600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA9YFMB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","XOMA","BK4139"],"gpt_icon":0},{"id":"2586250233","title":"Mural Oncology Plc - Total Cash Consideration of $2.035 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250233?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:00","pubTimestamp":1764165600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA9YFMB9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","BK4139","XOMA"],"gpt_icon":0},{"id":"2585480351","title":"BRIEF-Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585480351","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585480351?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:51","pubTimestamp":1763729511,"startTime":"0","endTime":"0","summary":"BRIEF-Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.Nov 21 (Reuters) - LAVA Therapeutics NV LVTX.O:XOMA ROYALTY ANNOUNCES CLOSING OF TRANSACTIONS TO ACQUIRE LAVA THER","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nTUA4CNKR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LVTX","XOMA"],"gpt_icon":0},{"id":"2585269148","title":"XOMA Royalty Closes Acquisition of LAVA Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2585269148","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585269148?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:45","pubTimestamp":1763729116,"startTime":"0","endTime":"0","summary":"XOMA Royalty Corporation has completed its previously announced acquisition of all outstanding common shares of LAVA Therapeutics N.V. LAVA shareholders received $1.04 in cash per share and a non-transferable contingent value right , which entitles holders to certain future cash payments. These payments include the right to receive 75% of any net proceeds related to LAVA's two partnered assets and from any out-license or sale of unpartnered programs, as well as up to approximately $0.23 per CVR, depending on the final determination of certain potential liabilities. Following the completion of the transaction, XOMA Royalty now owns 100% of LAVA's successor, and public trading of LAVA shares has been suspended with plans to delist from Nasdaq.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL7pmhjP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","LU2095319765.USD","NDAQ","XOMA","BK4139","IE00BKPKM429.USD","LVTX","BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU0314104364.USD"],"gpt_icon":0},{"id":"2585148415","title":"XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.v.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585148415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585148415?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:45","pubTimestamp":1763729100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nTUA4CNKR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LVTX","BK4539","XOMA","BK4139"],"gpt_icon":0},{"id":"2583022183","title":"UPDATE: XOMA Q3 Adj. EPS $(0.29) Misses $(0.04) Estimate, Adj. EPS Excludes Gains On Acquisitions Of $0.99 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2583022183","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583022183?lang=en_us&edition=fundamental","pubTime":"2025-11-13 03:59","pubTimestamp":1762977555,"startTime":"0","endTime":"0","summary":"UPDATE: XOMA Q3 Adj. EPS $(0.29) Misses $(0.04) Estimate, Adj. EPS Excludes Gains On Acquisitions Of $0.99 Per Share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48816485/update-xoma-q3-adj-eps-0-29-misses-0-04-estimate-adj-eps-excludes-gains-on-acquisitions-of-0-99-per","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"UPDATE: XOMA Q3 Adj. EPS $(0.29) Misses $(0.04) Estimate, Adj. EPS Excludes Gains On Acquisitions Of $0.99 Per Share","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOMA"],"gpt_icon":0},{"id":"2583306771","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), Xoma (XOMA) and Novavax (NVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583306771","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583306771?lang=en_us&edition=fundamental","pubTime":"2025-11-13 01:10","pubTimestamp":1762967439,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS – Research Report), Xoma (XOMA – Re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-xoma-xoma-and-novavax-nvax-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-xoma-xoma-and-novavax-nvax-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","NVAX","ALKS","XBI","BK4547","XOMA","HCSG","LU0128526141.USD","BK4137","BK4585","BK4588","BK4568","XLV","LU0029874061.USD","LABU"],"gpt_icon":0},{"id":"2582376679","title":"XOMA Q3 EPS $0.70 May Not Be Comparable To $(0.04) Estimate, Sales $9.351M Miss $11.467M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376679","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376679?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:37","pubTimestamp":1762951043,"startTime":"0","endTime":"0","summary":"XOMA Q3 EPS $0.70 May Not Be Comparable To $(0.04) Estimate, Sales $9.351M Miss $11.467M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799778/xoma-q3-eps-0-70-may-not-be-comparable-to-0-04-estimate-sales-9-351m-miss-11-467m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOMA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xoma.com","stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.1943},{"period":"3month","weight":-0.3197},{"period":"6month","weight":-0.0681},{"period":"1year","weight":-0.0571},{"period":"ytd","weight":-0.0266}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.589744,"avgChangeRate":0.056267},{"month":2,"riseRate":0.487179,"avgChangeRate":-0.011749},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.000111},{"month":4,"riseRate":0.487179,"avgChangeRate":-0.011164},{"month":5,"riseRate":0.538462,"avgChangeRate":0.057471},{"month":6,"riseRate":0.435897,"avgChangeRate":0.003996},{"month":7,"riseRate":0.45,"avgChangeRate":-0.005749},{"month":8,"riseRate":0.475,"avgChangeRate":0.052237},{"month":9,"riseRate":0.35,"avgChangeRate":-0.010798},{"month":10,"riseRate":0.4,"avgChangeRate":-0.033618},{"month":11,"riseRate":0.525,"avgChangeRate":0.022745},{"month":12,"riseRate":0.45,"avgChangeRate":0.042213}],"exchange":"NASDAQ","name":"XOMA Corp","nameEN":"XOMA Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XOMA Corp(XOMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest XOMA Corp(XOMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"XOMA Corp,XOMA,XOMA Corp股票,XOMA Corp股票老虎,XOMA Corp股票老虎国际,XOMA Corp行情,XOMA Corp股票行情,XOMA Corp股价,XOMA Corp股市,XOMA Corp股票价格,XOMA Corp股票交易,XOMA Corp股票购买,XOMA Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XOMA Corp(XOMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest XOMA Corp(XOMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction